Aug. 16, 2012 (China Knowledge) - Yunnan Baiyao Group Co Ltd<000538
>, one of China's leading pharmaceutical firms, booked RMB 724.53 million in net profit attributable to shareholders in the first half of this year, 28.44% more than in the same period of last year, according to a statement filed with the Shenzhen Stock Exchange
Basic earnings per share for the period were RMB 1.04, RMB 0.23 more than it realized in the first half of 2011.
From January to June 2012, the Shenzhen listed
pharmaceutical company saw its operation revenue reach RMB 6.08 billion, up 19.74% from a year earlier.
Operating revenue in core businesses exceeded RMB 6.06 billion in the six-month period, comprising RMB 6.02 billion from domestic market and RMB 38.96 million from overseas market, up 19.19% and 165.9% from a year earlier, respectively.